Interim Results

Clinical Computing PLC
26 September 2000


Clinical Computing plc
INTERIM RESULTS

Chairman's and Chief Executive's Statement

For the first half of 2000 the Group produced an operating profit of £84,000,
which together with net interest income of £73,000 generated a profit on
ordinary activities of £157,000.   The Group continued to have a strong cash
position with total cash and short-term deposits balances of approximately £3
million at the end of the first half of 2000.


Turnover for the first half of the year was £1.3 million, which is a decrease
of 15% on the same period of the prior year.   Total cost of sales for the
first half of the year decreased by 6% when compared to the same period of the
prior year.  Research and development costs, however, increased by 22%,
whereas other cost of sales decreased by 33%. Distribution costs remain at a
similar level to the same period of the prior year, but administrative
expenses have decreased by 24%.


With the introduction of the Clinical Vision product line, we expect to see a
reduction in the cash balances during the remainder of 2000 as we strengthen
our sales team in the US market and their activity increases. We are pleased
to announce that we have now recruited a new head of Sales and Marketing for
the US who has an extensive background in the sale of clinical systems.  Our
maintenance and support business remains strong in all markets. 


Despite some delays, Clinical Vision has been successfully implemented at our
two beta sites in the UK.  Both customers have upgraded to the latest
functionality of Version 3.0.  Version 3.1, which will be available in the
third quarter of this year, contains US billing interface and insurance
capture capabilities plus the protocols to allow for translation into other
languages. 

During the second half of the year the Group will focus on closing orders for
beta sites in the UK, Eire, New Zealand and the US, as well as the expansion
of the Clinical Vision product line into other specialties.  The Group
continues to explore technologies which will ensure that we stay current with
ever-changing market trends and that we have the software capability for the
complete electronic clinical record which health services need and will
demand. 


M Gordon                                   J Richardson
Chairman                                   Chief Executive



Unaudited Consolidated Profit and Loss Account
Six months ended 30 June 2000


                                        6 Months     6 Months         Year
                                           ended        ended        ended
                                        30.06.00     30.06.99     31.12.99
                                            £000         £000         £000
                     
Turnover                                   1,331        1,561        3,113
                     
Cost of sales                     
Research and development                     507          414          886
Other                                        279          419          780
                                            (786)        (833)      (1,666)
                     
Gross Profit                                 545          728        1,447
                     
Distribution costs                           220          216          413
Administrative expenses                      241          317          769
                                            (461)        (533)      (1,182)
                     
Operating profit                              84          195          265
                     
Net interest receivable                       73           58          117
                     
Profit on ordinary activities before         157          253          382
  and after taxation 
                     
Basic and diluted earnings per share        0.6p         1.0p         1.5p

All results are derived from continuing operations.



Unaudited Consolidated Statement of Total Recognised Gains and Losses
Six Months Ended 30 June 2000



                                        6 Months     6 Months         Year
                                           ended        ended        ended
                                        30.06.00     30.06.99     31.12.99
                                            £000         £000         £000

                     
Profit for the period                        157          253          382
                     
(Loss)/gain on foreign currency                     
translation                                  (33)         (38)         (25)
                     
                     
Total recognised gains and losses            124          215          357


Unaudited Consolidated Balance Sheet
30 June 2000

                                         30.06.00    30.06.99     31.12.99
                                             £000        £000         £000
                     
                     
                     
Tangible fixed assets                         313         341          345
                     
Current assets                     
Stocks                                         41          41           41
Debtors                                       727       1,137          748
Cash at bank and in hand                     
  (including short term deposits)           2,957       2,495        2,794
                                            3,725       3,673        3,583
                     
Creditors: Amounts falling due                              
within one year                     
Deferred income                               727         909          649
Other                                         216         268          308
                                              943       1,177          957
                     
                     
Net current assets                          2,782       2,496        2,626
                     
                     
Total assets less current liabilities       3,095       2,837        2,971
                     
Creditors: Amounts falling due                      
           After more than one 
           year                                 0          13            0
                     
                     
Net assets                                  3,095       2,824        2,971
                     
                     
Capital and reserves                     
Called-up share capital                     1,254       1,254        1,254
Share premium account                       4,248       4,248        4,248
Profit and loss account                    (2,407)     (2,678)      (2,531)
                     
Shareholders' funds - all equity            3,095       2,824        2,971



Unaudited Consolidated Cash Flow Statement
Six Months Ended 30 June 2000
                                                                      
                                         6 Months     6 Months        Year
                                            ended        ended       ended
                                         30.06.00     30.06.99    31.12.99
                                             £000         £000        £000
                     
                     
Operating profit                               84          195         265
                     
Depreciation and amortisation charges          75           71         144
(Increase)/decrease in debtors                 21          (70)        319
Increase/(decrease) in creditors              (14)           7        (178)
Unrealised foreign exchange loss              (33)           0         (27)
                     
Net cashflow from operating activities        133          203         523
                     
Returns on investments                         73           58         117
Capital expenditure                           (31)         (85)       (158)
                                               42          (27)        (41)
                     
Net cashflow before financing                 175          176         482
                     
Financing                                       0           (3)        (20)
                     
Increase in cash                              175          173         462


Notes

1. The interim results for the six months ended 30 June 
2000, set out here, have been compiled in accordance with 
applicable accounting standards and on a basis consistent 
with the annual accounts. They have been reviewed by our auditors, Arthur
Andersen, and a copy of their report is attached.  The auditors discussed
their review and findings with the Audit Committee.

2. The above financial information does not constitute 
statutory accounts within the meaning of Section 240 of the Companies Act
1985.  Group statutory accounts for the year ended 31 December 1999,which
included an unqualified audit report, have been filed with the Registrar of
Companies.

3. Basic earnings per share has been calculated on the basis 
of the weighted average number of shares in issue, being 25,080,310 for the
six months ended 30 June 2000, six months ended 30 June 1999, and for the year
ended 31 December 1999.

Diluted earnings per share has been calculated on the basis of the weighted
average number of shares in issue, being  25,426,926 for the six months ended
30 June 2000, six months ended 30 June 1999, and for the year ended 31
December 1999.

4. Copies of this interim report will be sent to 
shareholders and are available from the Company's head office at 4 Thameside
Centre, Kew Bridge Road, Brentford, Middlesex, TW8 0HF.

INDEPENDENT REVIEW REPORT TO CLINICAL COMPUTING PLC

Introduction
We have been instructed by the company to review the financial information set
out on pages 2 to 5 and we have read the other information contained in the
interim report and considered whether it contains any apparent misstatements
or material inconsistencies with the financial information.

Directors' responsibilities
The interim report, including the financial information contained therein, is
the responsibility of, and has been approved by, the directors.   The
directors are responsible for preparing the interim report in accordance with
the Listing Rules of the Financial Services Authority and applicable United
Kingdom accounting standards.  The Listing Rules require that the accounting
policies and presentation applied to the interim figures should be consistent
with those applied in preparing the preceding annual accounts except where any
changes, and the reasons for them, are disclosed.

Review work performed
We conducted our review in accordance with guidance contained in Bulletin
1999/4 issued in the United Kingdom by the Auditing Practices Board and with
our profession's ethical guidance. A review consists principally of making
enquiries of management and applying analytical procedures to the financial
information and underlying financial data and, based thereon, assessing
whether the accounting policies and presentation have been consistently
applied unless otherwise disclosed. A review excludes audit procedures such as
tests of controls and verification of assets, liabilities and transactions. It
is substantially less in scope than an audit performed in accordance with
Auditing Standards and therefore provides a lower level of assurance than an
audit. Accordingly we do not express an audit opinion on the financial
information.

Review conclusion
On the basis of our review we are not aware of any material modifications that
should be made to the financial information as presented for the six months
ended 30 June 2000.



Arthur Andersen
Chartered Accountants
Betjeman House
104 Hills Road
Cambridge CB2 1LH

Enquiries: 
Jack Richardson, Chief Executive
Clinical Computing plc
0208 380 4400